Results 41 to 50 of about 1,553,588 (375)

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10

open access: yesScientific Reports, 2021
Variants in the leucine-rich repeat kinase 2 (LRRK2) gene are associated with increased risk for familial and sporadic Parkinson’s disease (PD). Pathogenic variants in LRRK2, including the common variant G2019S, result in increased LRRK2 kinase activity,
Xiang Wang   +14 more
doaj   +1 more source

Pruritus in Keloid Scars: Mechanisms and Treatments

open access: yesActa Dermato-Venereologica, 2021
Keloids are scars that extend beyond the margins of an insulting cutaneous injury. Keloids are often thought to be primarily a cosmetic issue, as they are typically quite raised and pigmented. However, these scars also present with functional symptoms of
Ahmed A. Hawash   +3 more
doaj   +1 more source

Signaling pathways of chronic kidney diseases, implications for therapeutics

open access: yesSignal Transduction and Targeted Therapy, 2022
Chronic kidney disease (CKD) is a chronic renal dysfunction syndrome that is characterized by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) deposition.
Q. Yuan, B. Tang, Chun Zhang
semanticscholar   +1 more source

The Emerging Roles and Therapeutic Potential of Extracellular Vesicles in Infertility

open access: yesFrontiers in Endocrinology, 2021
Infertility is becoming much more common and affects more couples. The past years witnessed the rapid development of the diagnosis and treatment upon infertility, which give numerous coupled more opportunities become parents.
Guannan Zhou   +14 more
doaj   +1 more source

Therapeutics [PDF]

open access: yesAmerican Journal of Ophthalmology, 1918
n ...
openaire   +1 more source

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

open access: yesNew England Journal of Medicine, 2019
BACKGROUND Although several experimental therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial.
S. Mulangu   +50 more
semanticscholar   +1 more source

The current landscape of nucleic acid therapeutics

open access: yesNature Nanotechnology, 2021
The increasing number of approved nucleic acid therapeutics demonstrates the potential to treat diseases by targeting their genetic blueprints in vivo.
J. Kulkarni   +6 more
semanticscholar   +1 more source

Role of nanoparticles in tackling COVID-19 pandemic: a bio-nanomedical approach

open access: yesJournal of Taibah University for Science, 2021
COVID-19 Pandemic post threats to the life of millions of people across the globe as no specific therapeutics or vaccines have been scientifically proven.
Idris Zubairu Sadiq   +2 more
doaj   +1 more source

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development

open access: yesFrontiers in Immunology, 2021
The unprecedented 2015–2016 Zika outbreak in the Americas sparked global concern and drove the rapid deployment of vaccine and therapeutic countermeasures against this re-emerging pathogen.
Vincent Dussupt   +6 more
doaj   +1 more source

THERAPEUTICS [PDF]

open access: yesSouthern Medical Journal, 1913
n ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy